Therapeutics

Top Story

Latanoprostene bunod once daily found noninferior to timolol three times daily

June 20, 2016

Researchers found that daily evening treatments of latanoprostene bunod were noninferior to timolol twice daily for 3 months and resulted in significantly greater IOP lowering in subjects with open angle glaucoma or ocular hypertension, according to a study in the American Journal of Ophthalmology. 

This phase 3 study compared the IOP-lowering effect of latanoprostene bunod (LBN) 0.024% instilled once daily in the evening with timolol maleate 0.5% instilled twice daily in those with open angle glaucoma (OAG) or ocular hypertension, at 46 U.S. sites.

Perspectives on Glaucoma

Researchers find association between statin use, glaucoma incidence

June 15, 2016
Short-term statin use was found to be associated with a reduced incidence of glaucoma, but no association was found with IOP, according to a study in Investigative

Low-tech wearable device addresses issues with patient compliance

Primary Care Optometry News, June 2016
A new modular device may help increase compliance rates among patients taking ocular medications. A study by Okeke and colleagues showed that 45% of patients on glaucoma…

BLOG: Three reasons why MIGS may replace drops as first-line therapy

June 10, 2016
The use of minimally invasive glaucoma surgery has grown in the U.S. Here are three reasons why our old standard glaucoma drops may one day be relegated to second-line…

AOA warns consumers, alerts FDA of online vision tests

June 22, 2016
The American Optometric Association is educating consumers on the risks and limitations of online vision tests that…
More »

Smartphone technology facilitates retinal exam in primary care

June 21, 2016
The use of smartphones as ophthalmoscopes with the D-Eye retinal adapter and app is user friendly and “may help…
More »
Featured
ARVO

ARVO

Perspectives on Glaucoma

Glaucoma exams, treatment at community-based sites improve access to care

June 17, 2016
Researchers targeted individuals at risk for glaucoma in underserved Philadelphia communities, resulting in a detection…
More »
Perspectives on Glaucoma

Latanoprostene bunod once daily found noninferior to timolol three times daily

June 20, 2016
Researchers found that daily evening treatments of latanoprostene bunod were noninferior to timolol twice daily for 3 months and resulted in…

Perspectives on Glaucoma

Researchers find association between statin use, glaucoma incidence

June 15, 2016
Short-term statin use was found to be associated with a reduced incidence of glaucoma, but no association was found with IOP, according to a study in…

Low-tech wearable device addresses issues with patient compliance

Primary Care Optometry News, June 2016
A new modular device may help increase compliance rates among patients taking ocular medications. A study by Okeke and colleagues showed that 45% of…

BLOG: Three reasons why MIGS may replace drops as first-line therapy

June 10, 2016
The use of minimally invasive glaucoma surgery has grown in the U.S. Here are three reasons why our old standard glaucoma drops may one day be…

Topical EV06 improves near vision in patients with presbyopia

June 9, 2016
Twice-daily treatment with one drop of EV06 ophthalmic solution 1.5% improved distance-corrected near vision acuity efficacy measures when compared…

FDA News

FDA announces new 'streamlined' application for investigative drugs

June 2, 2016
The FDA has released a new application for investigative drugs that it says will cut the amount of time physicians spend filling out such requests…

Imprimis reports significant reduction in CME post cataract surgery

June 1, 2016
Investigators from Imprimis Pharmaceuticals announced positive clinical study results with its triamcinolone acetonide, moxifloxacin HCl and…

Emerging best practices improve ocular surface outcomes in glaucoma patients

Primary Care Optometry News, May 2016
Ian Benjamin Gaddie, OD
Ocular surface diseases, such as dry eye disease, can be caused by a number of triggers, including glaucoma treatment, allergies, computer use, the…

Meeting News Coverage

Study labels laser trabeculoplasty as adjunctive, not alternative, glaucoma treatment

May 12, 2016
SEATTLE – A retrospective analysis has found that 3 months after laser trabeculoplasty, 60% of open-angle glaucoma patients were prescribed at…

Meeting News Coverage

ARMOR study shows antibiotic resistance levels remain high

May 5, 2016
SEATTLE – Preliminary 2015 data from the Antibiotic Resistance Monitoring in Ocular Microorganism study show that high levels of antibiotic…

More Headlines »
morganatic-roan
morganatic-roan